Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Light application
Reexamination Certificate
1999-07-28
2004-10-19
Kearney, R. (Department: 3739)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Light application
C606S002000, C606S003000, C128S898000
Reexamination Certificate
active
06805701
ABSTRACT:
FIELD OF THE INVENTION
The present invention generally relates to a method of enhancing overall immune response in mammals.
BACKGROUND OF THE INVENTION
Attraction of leukocytes to the inflamed area is a known as a host response to infection. This process involves chemokines. Chemokines are small proteins, approximately 60-70 amino acids, containing cysteine residues which form disulfide bonds. Chemokines are chemotactic cytokines that have a special role in the pathophysiology of disease and may have a potential as targets of specific disease therapy.
The inflammatory responses are the result of a complex interplay between a variety of immune and nonimmune cells. The cytokines are the crucial mediators of tissue repair and inflammation. Cytokine is a general term for any non-antibody protein released by immune cells on contact with an antigen or an immune stimulant. They are produced by a wide array of cell types, such as mononuclear phagocyte, lymphocytes, and endothelial cells, and serve as communication signals among immunocompetent cells as well as between immune cells and connective tissue cells. Specifically, cytokines are involved in chemotaxis, adhesion to vascular endothelium, and subsequent transendothelial migration of leukocytes into target tissue; events that are crucial in the development of an inflammatory response. Endothelial cells when activated by the mononuclear cell-derived proinflammatory cytokines, interleuken-1 (IL-1), interleukin -6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-alpha), produce chemotactic cytokines such as IL-8 and express various molecules for leukocytes, thereby facilitating leukocyte extravasation.
Inflammation is the body's response to infection, or injury, so that activated immune cells release chemokines that draw immune cells to the local site. The area becomes red and warm, or inflamed. Lymphocytes are a family of white blood cells, or immune cells, which includes all types of T-cells and B-cells are primary elements of the antibody-mediated immune response; which also release cytokines which help trigger a wider range of cells, including T-cells. All B-cells are lymphocytes. T-cells are the main actors in the cell-mediated immune response; CD4+t cells and CD8+t cells are lymphocytes as are cytoxic t-lymphocytes (CTLs) and so called “Natural Killer” (NK cells); important in HIV infection.
The present invention generally relates to a method for the site specific enhancement of cytokine release (through chemotaxis) namely beta and alpha chemokines and enhance healing via an enhanced overall immune response.
SUMMARY OF THE INVENTION
The present invention generally relates to a method for the site specific enhancement of cytokine release (through chemotaxis) namely beta and alpha chemokines and enhance healing via an enhanced overall immune response. The site specific enhancement of cytokine release is achieved by initiating an inflammatory response by laser therapy.
REFERENCES:
patent: 5914255 (1999-06-01), Grae
Periodontal Disease and Respiratory Infections, Winter, 1999; Oral Health Letter School of Dental Medicine, vol. 1, No. 2, pp. 1-3.
Gum Disease and Heart Attacks A Connection, Fall, 1998; Oral Health Letter School of Dental Medicine, vol. 1, No. 1, pp. 1-5.
Charles W. Rhodes, DDS;Highly Focused ALD Conference Breaks All Records; Spring, 1999; Wavelengths, vol. 7, Issue 1.
Alan J. Goldstein, DMD;The Concept of Calibration or The Care and Maintenance of Our Ethical Barometers; Summer, 1998; Wavelengths, vol. 6, Issue 2.
Donald J. Coluzzi, DDS;FDA Grants Clearance For “Laser Curettage”; Spring, 1997; Wavelengths, vol. 5, Issue 1.
Alan J. Goldstein, DMD;To Communicate; Fall, 1998; Wavelengths, vol. 6, Issue 3.
Curriculum Guidelines and Standards for Dental Laser Education Undergo Significant Revision; Winter, 1998; Wavelengths, vol. 6, Issue 4.
Isao Ishikawa and Akira Aoki;The Role of Laser in Periodontics; Jan. 5, 1945; pp. 20-22.
Jorge Pinero, DDS;Nd: YAG-Assisted Periodontal Curettage to Prevent Bacteremia Before Cardiovascular Surgery; Mar. 1998; Dentistry Today, vol. 17, No. 3.
Jorge Pinero, DDS;The PPSP* Procedure: The Pinero Precardiac Surgical Protocol; Jan., 1999; Dentistry Today, vol. 18, No. 1.
Robert H. Gregg, DDS and Delwin K. McCarthy, DDS;Laser ENAP for Periodontal Ligament (PDL) Regeneration; Nov., 1998; Dentistry Today, vol. 17, No. 11.
Robert H. Gregg, DDS and Delwin K. McCarthy, DDS;Laser ENAP for Periodontal Bone Regeneration; May, 1998; Dentistry Today, vol. 17, No. 5.
Bonnie Heald;Zeroing In on Gum Disease; Insight.
Robert H. Gregg, DDS;Lasers in General Dentistry; Laser Dentist.
Robert H. Gregg, DDS;Dental Laser ENAP; Laser Dentist.
C. J. Whitters, et al.;The Bactericidal Activity of Pulsed Nd-YAG Laser Radiation In Vitro; Oct., 1994; Lasers in Medical Science, pp. 297-302.
Cortes Marta
Kearney R.
Mancini Ralph J.
LandOfFree
Method of enhancing immune response does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of enhancing immune response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of enhancing immune response will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3276847